Skip to content

Study for the Mechanism of Cangfu Dutan decoction in the treatment of phlegm-dampness PCOS Infertility from the Perspective of Lipid Metabolism

Study for the Mechanism of Cangfu Dutan decoction in the treatment of phlegm-dampness PCOS Infertility from the Perspective of Lipid Metabolism

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023712
Enrollment
Unknown
Registered
2019-06-08
Start date
2018-03-01
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome

Interventions

Sponsors

Shandong Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria. 1.1 phlegm-dampness syndrome PCOS group (experimental group, observation group). (1) meeting the age standard of < 35 years old; (2) it meets the diagnostic criteria of multi-PCOS, sterility, spleen deficiency and phlegm-dampness syndrome; (3) there was no abnormality in the anatomical structure of reproductive organs;(4) the semen level of male was about normal; (5) sign the informed consent form. 1.2 non-phlegm-dampness syndrome PCOS group (control group). It met the diagnostic criteria of PCOS and sterility, but not the diagnostic criteria of spleen deficiency and phlegm-dampness syndrome, and the other criteria were the same as those of phlegm-dampness syndrome PCOS group.

Exclusion criteria

Exclusion criteria: Exclusion standard. (1) those who had used any drugs that affected the level of hormone, glucose and lipid metabolism in human body 3 months before treatment;(2) patients with severe mental illness;(3) patients with hypothalamic, pituitary, hyperprolactinemia, thyroid diseases and other diseases;(4) abnormal chromosome in peripheral blood of husband and wife; (5) patients with incomplete information.

Design outcomes

Primary

MeasureTime frame
visfatin;Free fatty acid;

Secondary

MeasureTime frame
estradiol;Luteinizing hormone;

Countries

China

Contacts

Public ContactHaiyan Zhang

Shandong Hospital of Traditional Chinese Medicine

530319196@qq.com+86 15628967606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026